Long-term retrospective study of Tocilizumab in patients with Rheumatoid Arthritis who are refractory to DMARDs, anti-TNF and rituximab.
Phase of Trial: Phase IV
Latest Information Update: 23 Aug 2016
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- 23 Aug 2016 New trial record